Back to search

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF

Data up to Jan 2025

Published1987
Citations105
References24

Total Citations Per Year

Abstract

References (24)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

1973 • 2,615 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat

1982 • 1,693 citations

Dopamine (3-hydroxytyramine) and brain function.

1966 • 1,401 citations

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1979 • 1,356 citations

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1984 • 913 citations

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1983 • 712 citations

Is the mesocortical dopaminergic system involved in Parkinson disease?

1980 • 412 citations

The Clinical Syndrome of Striatal Dopamine Deficiency

1985 • 241 citations

3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activity

1979 • 213 citations

Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus

1985 • 155 citations

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

1978 • 130 citations

Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates

1982 • 121 citations

N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.

1984 • 75 citations

Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome

1977 • 73 citations

Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1986 • 72 citations

The use of C8-octyl columns for the analysis of catecholamines by ion-pair reversed-phase liquid chromatography with amperometric detection

1981 • 68 citations

Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum

1987 • 66 citations

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains

1982 • 63 citations

Organization of mesencephalic dopamine neurons projecting to neocortex and septum.

1977 • 54 citations

Relative Importance of 3‐Methoxy‐4‐Hydroxyphenylglycol and 3,4‐Dihydroxyphenylglycol as Norepinephrine Metabolites in Rat, Monkey, and Humans

1983 • 54 citations

Origin of brain stem and temporal cortical afferent fibers to the septal region in the squirrel monkey

1981 • 14 citations

Cited By (0)

Loading...
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and… (1987) – Brain Research | Metascience Observatory Explorer